Strictly screening of HTLV-1/2 peptides can drive the development of rapid point-of-care tests

Post time Half hour(s) ago

revista：Journal of Virological Methods

Autores：Laura Jorge Cox; Vanessa Gomes Fraga; Ricardo Toshio Fujiwara; Danielle SO Daian e Silva; Gabriela Melo Franco; Anderson Santos Rocha; Tatyane M. Cirilo; Marina L. Martins; Agostinho G. Viana; Adele Caterino-de-Araújo; Antonio CR Vallinoto; Edel F. Barbosa-Stancioli

Data de publicação：2025-7-

DOI：10.1016/j.jviromet.2025.115170

Link PDF：https://www.sciencedirect.com/sc ... 166093425000631/pdf

Artigo link: https://doi.org/10.1016/j.jviromet.2025.115170

Fonte do artigo: Elsevier BV .

Observação:

Post time Half hour(s) ago

: Waiting for confirmation
If the PDF has not been accepted after 72 hours, the system will automatically adopt it.

[Elsevier] Strictly screening of HTLV-1/2 peptides can drive the development of rapid point-of-care tests

Same Category

Latest Reply

Announcement

Daily Top Contributors

[Elsevier] Strictly screening of HTLV-1/2 peptides can drive the development of rapid point-of-care tests Copy

Same Category

Latest Reply

Announcement

Daily Top Contributors

[Elsevier] Strictly screening of HTLV-1/2 peptides can drive the development of rapid point-of-care tests